Hong Yu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hong Yu Wang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Adam Rothman
Division of Pulmonary, Department of Medicine, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai West and Mount Sinai Morningside, New York, USA
1 shared publication- Fnu Sadarat
Department of Internal Medicine, University of Buffalo, New York, NY 14215, USA
1 shared publication Javier J. Zulueta
Department of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, USA
1 shared publicationJunyu Qi
Department of Medicine, Division of Pulmonary Medicine, Mount Sinai Morningside Hospital, New York, USA
1 shared publication- Lorenzo Leys
Department of Internal Medicine, Mount Sinai Beth Israel, New York, NY 10003, USA
1 shared publication Monica SanJuan
Department of Medicine, Division of Pulmonary Medicine, Mount Sinai Morningside Hospital, New York, USA
1 shared publication
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in BMC Pulmonary Medicine
Predictors and disparities in surveillance of incidental lung nodules in a diverse urban population: a retrospective observational study
- 28 October 2026
- Published by Springer Nature in BMC Pulmonary Medicine
Open AccessPredictors and disparities in surveillance of incidental lung nodules in a diverse urban population: a retrospective observational study
- Open Access
- 11 June 2025
- Published by Wolters Kluwer Health in Journal of Medical Ultrasound
- Vol. 34 (1) , 42-46
Deliberate Practice in Point-of-care Ultrasound Interpretation of Hydronephrosis
Background: Point-of-care ultrasound (POCUS) has become increasingly utilized as an important tool in acute care settings. Deliberate practice as part of POCUS training has previously been shown to enhance learner performance in image interpretation, though its efficacy in residents’ identification of hydronephrosis with renal POCUS has not been well-studied. In our study, we aimed to evaluate the learning curve for internal medicine residents using deliberate practice for the identification of hydronephrosis on renal POCUS interpretation. Methods: We recruited internal medicine residents from Mount Sinai Beth Israel and Mount Sinai Morningside/West, and asked them to complete a 30-case educational instrument on the interpretation of hydronephrosis. The study was conducted as a series of two separate hour-long sessions and included residents with varying baseline POCUS experience. We mapped cumulative accuracy as learning curves to assess resident performance. Results: A total of 47 participants completed the survey and deliberate practice instrument and demonstrated significant improvement in confidence level and image interpretation skills. All learners demonstrated improvement in accuracy with repetitive practice. We mapped the learning curve and found a plateau in accuracy at 20–25 cases. Statistical analysis of the results was performed with Microsoft Excel Version 16.85, and R version 4.3.2. Conclusion: Deliberate practice in the identification of hydronephrosis on renal POCUS using a novel case-based instrument improves residents’ accuracy. This approach is easily reproducible, can impact learners at different stages of experience, and can be integrated into a more comprehensive curriculum on POCUS.
- 11 June 2025
- Published by Wolters Kluwer Health in Journal of Medical Ultrasound
- Vol. 34 (1) , 42-46
Open AccessDeliberate Practice in Point-of-care Ultrasound Interpretation of Hydronephrosis
Background: Point-of-care ultrasound (POCUS) has become increasingly utilized as an important tool in acute care settings. Deliberate practice as part of POCUS training has previously been shown to enhance learner performance in image interpretation, though its efficacy in residents’ identification of hydronephrosis with renal POCUS has not been well-studied. In our study, we aimed to evaluate the learning curve for internal medicine residents using deliberate practice for the identification of hydronephrosis on renal POCUS interpretation. Methods: We recruited internal medicine residents from Mount Sinai Beth Israel and Mount Sinai Morningside/West, and asked them to complete a 30-case educational instrument on the interpretation of hydronephrosis. The study was conducted as a series of two separate hour-long sessions and included residents with varying baseline POCUS experience. We mapped cumulative accuracy as learning curves to assess resident performance. Results: A total of 47 participants completed the survey and deliberate practice instrument and demonstrated significant improvement in confidence level and image interpretation skills. All learners demonstrated improvement in accuracy with repetitive practice. We mapped the learning curve and found a plateau in accuracy at 20–25 cases. Statistical analysis of the results was performed with Microsoft Excel Version 16.85, and R version 4.3.2. Conclusion: Deliberate practice in the identification of hydronephrosis on renal POCUS using a novel case-based instrument improves residents’ accuracy. This approach is easily reproducible, can impact learners at different stages of experience, and can be integrated into a more comprehensive curriculum on POCUS.
- Open Access
- 28 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (7) , 2555
Glycemic Control in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Background: Given the mortality risk in COVID-19 patients, it is necessary to estimate the impact of glycemic control on mortality rates among inpatients by designing and implementing evidence-based blood glucose (BG) control methods. There is evidence to suggest that COVID-19 patients with hyperglycemia are at risk of mortality, and glycemic control may improve outcomes. However, the optimal target range of blood glucose levels in critically ill COVID-19 patients remains unclear, and further research is needed to establish the most effective glycemic control strategies in this population. Methods: The investigation was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Data sources were drawn from Google Scholar, ResearchGate, PubMed (MEDLINE), Cochrane Library, and Embase databases. Randomized controlled trials, non-randomized controlled trials, retrospective cohort studies, and observational studies with comparison groups specific to tight glycemic control in COVID-19 patients with and without diabetes. Results: Eleven observational studies (26,953 patients hospitalized for COVID-19) were included. The incidence of death was significantly higher among COVID-19 patients diagnosed with diabetes than those without diabetes (OR = 2.70 [2.11, 3.45] at a 95% confidence interval). Incidences of death (OR of 3.76 (3.00, 4.72) at a 95% confidence interval) and complications (OR of 0.88 [0.76, 1.02] at a 95% confidence interval) were also significantly higher for COVID-19 patients with poor glycemic control. Conclusion: These findings suggest that poor glycemic control in critically ill patients leads to an increased mortality rate, infection rate, mechanical ventilation, and prolonged hospitalization.
- 28 March 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (7) , 2555
Open AccessGlycemic Control in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Background: Given the mortality risk in COVID-19 patients, it is necessary to estimate the impact of glycemic control on mortality rates among inpatients by designing and implementing evidence-based blood glucose (BG) control methods. There is evidence to suggest that COVID-19 patients with hyperglycemia are at risk of mortality, and glycemic control may improve outcomes. However, the optimal target range of blood glucose levels in critically ill COVID-19 patients remains unclear, and further research is needed to establish the most effective glycemic control strategies in this population. Methods: The investigation was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Data sources were drawn from Google Scholar, ResearchGate, PubMed (MEDLINE), Cochrane Library, and Embase databases. Randomized controlled trials, non-randomized controlled trials, retrospective cohort studies, and observational studies with comparison groups specific to tight glycemic control in COVID-19 patients with and without diabetes. Results: Eleven observational studies (26,953 patients hospitalized for COVID-19) were included. The incidence of death was significantly higher among COVID-19 patients diagnosed with diabetes than those without diabetes (OR = 2.70 [2.11, 3.45] at a 95% confidence interval). Incidences of death (OR of 3.76 (3.00, 4.72) at a 95% confidence interval) and complications (OR of 0.88 [0.76, 1.02] at a 95% confidence interval) were also significantly higher for COVID-19 patients with poor glycemic control. Conclusion: These findings suggest that poor glycemic control in critically ill patients leads to an increased mortality rate, infection rate, mechanical ventilation, and prolonged hospitalization.